Monthly Archives: October 2015

Australian Patent Office Proposes “Coding Only” Sequence Ban

Coming soon after the High Court’s “Myriad decision” in Australia, the Australian Patent Office has proposed guidelines that would effectively limit the ban on patent-eligibility of DNA sequences to nucleic acids that code for polypeptides. While cDNA is still considered … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , | Leave a comment

Takeaways from Chisum’s Washington, D.C. September 2015 Seminar

On September 24-25, 2015, the Chisum Patent Academy held a two-day seminar at the offices of Kaye Scholer LLP in Washington, DC to discuss and debate current developments in U.S. patent law. The roundtable seminar group was limited to ten … Continue reading

Posted in Conferences and Classes, Miscellaneous, People | Tagged , , , , , , | Leave a comment

Janice Mueller’s New Article: Patent -Ineligible Methods of Treatment

Patent-Ineligible Methods of Treatment Janice M. Mueller  Chisum Patent Academy October 3, 2015 Janice M. Mueller, Patent-Ineligible Methods of Treatment, in MUELLER ON PATENT LAW, VOL. I (PATENTABILITY AND VALIDITY) (Wolters Kluwer Law & Business 2012), last revised October 2015 … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | 1 Comment

USPTO Report on State of Confirmatory Genetic Testing Comes off the Waffle Iron

In 2011—after the Fed. Cir. decision in Myriad upholding claims to BRACA1 and 2 genes—the PTO was tasked by a section of the AIA with providing Congress with a report on the effect of patenting on confirmatory genetic testing. The … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment